Medicine Platform
搜索
Product Catagories
首页 > Pharmaceutical Materials > 98% up by HPLC Sugammadex Sodium 343306-79-6
98% up by HPLC Sugammadex Sodium 343306-79-6
单价 面议对比
询价 暂无
发货 全国
过期 长期有效
更新 2025-08-13 23:39
 
详细信息

Grade: Pharmaceutical Grade

Factory Location: Xiamen, Fujian

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East

Monthly Production Capacity: 1000kg

Packaging Information: 25kg/drum 1kg/bottle

Delivery Lead Time: 7 days after payment

Sample Provided: yes

Payment Terms: L/L

Product Information

 

Product name

Sugammadex Sodium

CAS No.

343306-79-6

Molecular Formula

C72H104Na8O48S8

Molecular Weight

2177.97

Quality Standard

98% up

Appearance

White powder

 

 

 

COA of Sugammadex Sodium

 

ITEM

VALUE

RESULT

Na5P3O10 (%)

95 MIN

96.5

P2O5 (%)

56.0MIN

57.6

F (mg/kg)

10MAX

5

As (mg/kg)

1MAX

<0.5

Pb (mg/kg)

1MAX

<1

Hg (mg/kg)

1MAX

<1

Cd (mg/kg)

1MAX

<1

WATER INSOLUBLES (%)

0.1MAX

0.02

pH (1% solution)

9.1-10.2

9.69

Density (g/cm3)

0.73 MIN

0.85

Heavy Metal (as Pb) ((mg/kg))

10 MAX

<10

Conclusion

Analysis Conclusion: Qualified

 

Usage

 

Sugammadex Sodium is the first and only selective relaxation binder, a major advancement in the field of muscle relaxants in the past 20 years. It allows the anesthesiologist to control the degree of muscle relaxation during the entire operation and increase the number of The quality of millions of operations represents the first major advancement in 20 years, making it possible to reverse surgical anesthesia.

 

Advantage of Sugammadex Sodium

1. The effect is remarkable and the effect is fast. The effect of antagonizing moderate and deep muscle relaxation can be quickly reversed, and the effect is complete. The average time from deep muscle relaxation to functional recovery is only 2-3 minutes.

2. Good tolerance and low incidence of adverse reactions. For some special populations, such as obese patients, elderly patients, children aged 2-17, patients with heart disease, patients with lung disease, and those with mild to moderate liver and kidney damage, no dose adjustment is required.